Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Thyroid gland

Thyroid surgery and radioiodine ablation—the surgeon's role

Nature Reviews Endocrinology volume 9, pages 140–141 (2013)Cite this article

Subjects

Total thyroidectomy and subsequent radioiodine ablation improve the outcome of patients with thyroid tumours measuring >1 cm. Best practice guidelines should serve as a basis for clinical decision making in stage I thyroid cancer; however, Haymart et al. report that soft factors, unrelated to clinical presentation, affect the rate of radioiodine ablation.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Haymart, M. R. et al. The relationship between extent of thyroid cancer and use of radioactive iodine. Ann. Surg. http://dx.doi.org/10.1097/SLA.0b013e31826c8915.

  2. Verburg, F. A., Mäder, U., Kruitwagen, C. L., Luster, M. & Reiners, C. A comparison of prognostic classification systems for differentiated thyroid carcinoma. Clin. Endocrinol. (Oxf.) 72, 830–838 (2010).

    Article  Google Scholar 

  3. Trocchi, P. et al. Thyroid cancer surgery in Germany: an analysis of the nationwide DRG statistics 2005–2006. Langenbecks Arch. Surg. 397, 421–428 (2012).

    Article  Google Scholar 

  4. Biermann, M. et al. Guidelines on radioiodine therapy for differentiated thyroid carcinoma: impact on clinical practice. Nuklearmedizin 44, 229–237 (2005).

    Article  CAS  Google Scholar 

  5. Dietlein, M., Luyken, W. A., Schicha, H. & Larena-Avellaneda, A. Incidental multifocal papillary microcarcinomas of the thyroid: is subtotal thyroidectomy combined with radioiodine ablation enough? Nucl. Med. Commun. 26, 3–8 (2005).

    Article  Google Scholar 

  6. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19, 1167–1214 (2009).

  7. Sawka, A. M. et al. An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol. Metab. Clin. North Am. 37, 457–480 (2008).

    Article  Google Scholar 

  8. Verburg, F. A. No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer. Eur. J. Nucl. Med. Mol. Imaging 37, 276–283 (2010).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany

    Markus Luster

  2. Department of General, Section of Endocrine Surgery, Visceral and Transplantation Surgery, University Medical Centre, Johannes Gutenberg University Mainz, Langenbeckstrasse 1, Mainz, 55131, Germany

    Thomas J. Musholt

Authors
  1. Markus Luster
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas J. Musholt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Markus Luster.

Ethics declarations

Competing interests

M. Luster is a consultant to and member of the speaker's bureau of Genzyme Corp. and serves as consultant and advisor for Bayer HealthCare Pharmaceuticals. T. J. Musholt declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luster, M., Musholt, T. Thyroid surgery and radioiodine ablation—the surgeon's role. Nat Rev Endocrinol 9, 140–141 (2013). https://doi.org/10.1038/nrendo.2012.229

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2012.229

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing